Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 182 articles: HTML format Text format

Single Articles

March 2010
1. MIN Y , Ren X, Vaught DB, Chen J, et al
   Tie2 Signaling Regulates Osteoclastogenesis and Osteolytic Bone Invasion of Breast Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. LIN L , Hutzen B, Zuo M, Ball S, et al
   Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. CHOI YL , Bocanegra M, Kwon MJ, Young Kee S, et al
   LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. YANG XH , Flores LM, Li Q, Zhou P, et al
   Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LIN J , Lee IM, Song Y, Cook NR, et al
   Plasma Homocysteine and Cysteine and Risk of Breast Cancer in Women.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. EFFERSON CL , Winkelmann CT, Ware C, Sullivan T, et al
   Downregulation of Notch Pathway by a {gamma}-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
7. ZHONG Z , Yeow WS, Zou C, Wassell R, et al
   Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. TURNER N , Pearson A, Sharpe R, Lambros M, et al
   FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. RAY RB , Raychoudhuri A, Steele R, Nerurkar P, et al
   Bitter Melon (Momordica charantia) Extract Inhibits Breast Cancer Cell Proliferation by Modulating Cell Cycle Regulatory Genes and Promotes Apoptosis.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. OOI LL , Zhou H, Kalak R, Zheng Y, et al
    Vitamin D Deficiency Promotes Human Breast Cancer Growth in a Murine Model of Bone Metastasis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. KOURTIDIS A , Jain R, Carkner RD, Eifert C, et al
    An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. ODEFREY F , Stone J, Gurrin LC, Byrnes GB, et al
    Common Genetic Variants Associated with Breast Cancer and Mammographic Density Measures That Predict Disease.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. JOFFROY CM , Buck MB, Stope MB, Popp SL, et al
    Antiestrogens Induce Transforming Growth Factor {beta}-Mediated Immunosuppression in Breast Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. MCILROY M , McCartan D, Early S, Gaora PO, et al
    Interaction of Developmental Transcription Factor HOX11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. HOLLAND SJ , Pan A, Franci C, Hu Y, et al
    R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. RANGASAMY V , Mishra R, Mehrotra S, Sondarva G, et al
    Estrogen Suppresses MLK3-Mediated Apoptosis Sensitivity in ER+ Breast Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. TRAN TH , Utama FE, Lin J, Yang N, et al
    Prolactin Inhibits BCL6 Expression in Breast Cancer through a Stat5a-Dependent Mechanism.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. DUTERTRE M , Lacroix-Triki M, Driouch K, de la Grange P, et al
    Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
    Cancer Res. 2010;70:896-905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LAMBER EP , Horwitz AA, Parvin JD
    BRCA1 represses amphiregulin gene expression.
    Cancer Res. 2010;70:996-1005.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. MCKEEN HD , Byrne C, Jithesh PV, Donley C, et al
    FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.
    Cancer Res. 2010;70:1090-100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. RANSBURGH DJ , Chiba N, Ishioka C, Toland AE, et al
    Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.
    Cancer Res. 2010;70:988-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
22. SONG F , Ji P, Zheng H, Song F, et al
    Definition of a Functional Single Nucleotide Polymorphism in the Cell Migration Inhibitory Gene MIIP That Affects the Risk of Breast Cancer.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. HUANG X , Gao L, Wang S, McManaman JL, et al
    Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. GUSTAFSSON N , Zhao C, Gustafsson JA, Dahlman-Wright K, et al
    RBCK1 Drives Breast Cancer Cell Proliferation by Promoting Transcription of Estrogen Receptor {alpha} and Cyclin B1.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. TRUITT L , Freywald T, Decoteau J, Sharfe N, et al
    The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. PAPAGEORGIS P , Lambert AW, Ozturk S, Gao F, et al
    Smad Signaling Is Required to Maintain Epigenetic Silencing during Breast Cancer Progression.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ARIAZI EA , Brailoiu E, Yerrum S, Shupp HA, et al
    The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. CONFORTI R , Ma Y, Morel Y, Paturel C, et al
    Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.
    Cancer Res. 2010;70:490-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MCCUNE K , Bhat-Nakshatri P, Thorat MA, Nephew KP, et al
    Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
    Cancer Res. 2010;70:685-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. MA H , Wang Y, Sullivan-Halley J, Weiss L, et al
    Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. HARRISON H , Farnie G, Howell SJ, Rock RE, et al
    Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. SEITZER N , Mayr T, Streit S, Ullrich A, et al
    A Single Nucleotide Change in the Mouse Genome Accelerates Breast Cancer Progression.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. NOVOSYADLYY R , Lann DE, Vijayakumar A, Rowzee A, et al
    Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. WANG L , Ellsworth KA, Moon I, Pelleymounter LL, et al
    Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
    Cancer Res. 2010;70:319-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
35. BROWN KA , Simpson ER
    Obesity and Breast Cancer: Progress to Understanding the Relationship.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
36. DRIOUCH K , Bonin F, Sin S, Clairac G, et al
    Confounding Effects in "A Six-Gene Signature Predicting Breast Cancer Lung Metastasis": Reply.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. PATSIALOU A , Wyckoff J, Wang Y, Goswami S, et al
    Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. TAMIMI RM , Colditz GA, Hankinson SE
    Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. KANDA T , Raychoudhuri A, Steele R, Sagartz JE, et al
    MBP-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. CHEN L , Mayer JA, Krisko TI, Speers CW, et al
    Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SONG H , Hobbs RF, Vajravelu R, Huso DL, et al
    Radioimmunotherapy of Breast Cancer Metastases with {alpha}-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. FRASOR J , Weaver A, Pradhan M, Dai Y, et al
    Positive Cross-Talk between Estrogen Receptor and NF-{kappa}B in Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. CHEN H , Zhu G, Li Y, Padia RN, et al
    Extracellular Signal-Regulated Kinase Signaling Pathway Regulates Breast Cancer Cell Migration by Maintaining slug Expression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. KUO PC , Tsao YP, Chang HW, Chen PH, et al
    Breast Cancer Amplified Sequence 2, a Novel Negative Regulator of the p53 Tumor Suppressor.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. PANG H , Flinn R, Patsialou A, Wyckoff J, et al
    Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. YAMAGUCHI H , Takeo Y, Yoshida S, Kouchi Z, et al
    Lipid Rafts and Caveolin-1 Are Required for Invadopodia Formation and Extracellular Matrix Degradation by Human Breast Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. LIU S , Goldstein RH, Scepansky EM, Rosenblatt M, et al
    Inhibition of Rho-Associated Kinase Signaling Prevents Breast Cancer Metastasis to Human Bone.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. UEKI T , Park JH, Nishidate T, Kijima K, et al
    Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. LESNIAK D , Xu Y, Deschenes J, Lai R, et al
    {beta}1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
50. DOMSCHKE C , Schuetz F, Ge Y, Seibel T, et al
    Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. REIM F , Dombrowski Y, Ritter C, Buttmann M, et al
    Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells.
    Cancer Res. 2009;69:8058-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. HUANG X , Gao L, Wang S, Lee CK, et al
    HDAC Inhibitor SNDX-275 Induces Apoptosis in erbB2-Overexpressing Breast Cancer Cells via Down-regulation of erbB3 Expression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. DAIRKEE SH , Sayeed A, Luciani G, Champion S, et al
    Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.
    Cancer Res. 2009;69:7826-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
54. DE S , Cipriano R, Jackson MW, Stark GR, et al
    Overexpression of Kinesins Mediates Docetaxel Resistance in Breast Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. FLEMING NI , Trivett MK, George J, Slavin JL, et al
    Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
    Cancer Res. 2009;69:7473-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. ANTONESCU CR , Yoshida A, Guo T, Chang NE, et al
    KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.
    Cancer Res. 2009;69:7175-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. SAETROM P , Biesinger J, Li SM, Smith D, et al
    A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. CULHANE AC , Quackenbush J
    Confounding Effects in "A Six-Gene Signature Predicting Breast Cancer Lung Metastasis"
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
59. SOLAZZO M , Fantappie O, D'Amico M, Sassoli C, et al
    Mitochondrial Expression and Functional Activity of Breast Cancer Resistance Protein in Different Multiple Drug-Resistant Cell Lines.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. KADOTA M , Sato M, Duncan B, Ooshima A, et al
    Identification of Novel Gene Amplifications in Breast Cancer and Coexistence of Gene Amplification with an Activating Mutation of PIK3CA.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. LI CI , Daling JR, Porter PL, Tang MT, et al
    Adjuvant Hormonal Therapy for Breast Cancer and Risk of Hormone Receptor-Specific Subtypes of Contralateral Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. PRATAP J , Imbalzano KM, Underwood JM, Cohet N, et al
    Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. THIOLLOY S , Halpern J, Holt GE, Schwartz HS, et al
    Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
    Cancer Res. 2009;69:6747-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. FARATIAN D , Goltsov A, Lebedeva G, Sorokin A, et al
    Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab.
    Cancer Res. 2009;69:6713-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. WALIA V , Ding M, Kumar S, Nie D, et al
    hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. MIN C , Yu Z, Kirsch KH, Zhao Y, et al
    A Loss-of-Function Polymorphism in the Propeptide Domain of the LOX Gene and Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. PAJIC M , Iyer JK, Kersbergen A, van der Burg E, et al
    Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. PETERS AA , Buchanan G, Ricciardelli C, Bianco-Miotto T, et al
    Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
    Cancer Res. 2009;69:6131-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. ALI S , Heathcote DA, Kroll SH, Jogalekar AS, et al
    The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity.
    Cancer Res. 2009;69:6208-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. FAN S , Meng Q, Saha T, Sarkar FH, et al
    Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner.
    Cancer Res. 2009;69:6083-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. LIAO HJ , Carpenter G
    Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor.
    Cancer Res. 2009;69:6179-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. MAURER M , Su T, Saal LH, Koujak S, et al
    3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
    Cancer Res. 2009;69:6299-306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. TEOH ML , Fitzgerald MP, Oberley LW, Domann FE, et al
    Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
    Cancer Res. 2009;69:6355-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. SONG N , Huang Y, Shi H, Yuan S, et al
    Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
    Cancer Res. 2009;69:6057-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
75. FISTER S , Gunthert AR, Aicher B, Paulini KW, et al
    GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. YANG E , Boire A, Agarwal A, Nguyen N, et al
    Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. DEBLOIS G , Hall JA, Perry MC, Laganiere J, et al
    Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor {alpha} as a Determinant of Breast Cancer Heterogeneity.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. POPOV VM , Zhou J, Shirley LA, Quong J, et al
    The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
    Cancer Res. 2009;69:5752-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. BON G , Di Carlo SE, Folgiero V, Avetrani P, et al
    Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
    Cancer Res. 2009;69:5978-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. KIM SH , Castro F, Paterson Y, Gravekamp C, et al
    High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. MARELLA NV , Malyavantham KS, Wang J, Matsui SI, et al
    Cytogenetic and cDNA Microarray Expression Analysis of MCF10 Human Breast Cancer Progression Cell Lines.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. RAY-COQUARD I , Cropet C, Van Glabbeke M, Sebban C, et al
    Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
    Cancer Res. 2009;69:5383-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
83. OLKHANUD PB , Baatar D, Bodogai M, Hakim F, et al
    Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. HOFFMAN AE , Zheng T, Yi C, Leaderer D, et al
    microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. XIE Y , Wolff DW, Wei T, Wang B, et al
    Breast Cancer Migration and Invasion Depend on Proteasome Degradation of Regulator of G-Protein Signaling 4.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. DIMEO TA , Anderson K, Phadke P, Feng C, et al
    A Novel Lung Metastasis Signature Links Wnt Signaling with Cancer Cell Self-Renewal and Epithelial-Mesenchymal Transition in Basal-like Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. LIN BC , Suzawa M, Blind RD, Tobias SC, et al
    Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. CHAMBERS AF
    MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. FUNASAKA T , Hogan V, Raz A
    Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. NOVAK P , Jensen TJ, Garbe JC, Stampfer MR, et al
    Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization.
    Cancer Res. 2009;69:5251-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. HECK S , Rom J, Thewes V, Becker N, et al
    Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
    Cancer Res. 2009;69:5186-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. RAINA D , Ahmad R, Joshi MD, Yin L, et al
    Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
    Cancer Res. 2009;69:5133-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. BROWN KA , McInnes KJ, Hunger NI, Oakhill JS, et al
    Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. ZHANG H , Xu X, Gajewiak J, Tsukahara R, et al
    Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. HELMS MW , Kemming D, Contag CH, Pospisil H, et al
    TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. BARONE I , Cui Y, Herynk MH, Corona-Rodriguez A, et al
    Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
    Cancer Res. 2009;69:4724-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MARETZKY T , Le Gall SM, Worpenberg-Pietruk S, Eder J, et al
    Src stimulates fibroblast growth factor receptor-2 shedding by an ADAM15 splice variant linked to breast cancer.
    Cancer Res. 2009;69:4573-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
98. LU J , Steeg PS, Price JE, Krishnamurthy S, et al
    Breast Cancer Metastasis: Challenges and Opportunities.
    Cancer Res. 2009.
    PubMed     Text format     Related articles   
    
    
    
99. JAGER M , Schoberth A, Ruf P, Hess J, et al
    The trifunctional antibody ertumaxomab destroys tumor cells that express low levels of human epidermal growth factor receptor 2.
    Cancer Res. 2009;69:4270-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. DATTA J , Ghoshal K, Denny WA, Gamage SA, et al
     A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
     Cancer Res. 2009;69:4277-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. SUN W , Kalen AL, Smith BJ, Cullen JJ, et al
     Enhancing the antitumor activity of adriamycin and ionizing radiation.
     Cancer Res. 2009;69:4294-300.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. DEMICHELE A , Gray R, Horn M, Chen J, et al
     Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. HENNESSY BT , Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, et al
     Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. MILLER TW , Perez-Torres M, Narasanna A, Guix M, et al
     Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. RAHMAN KW , Banerjee S, Ali S, Ahmad A, et al
     3,3'-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. MILANI M , Rzymski T, Mellor HR, Pike L, et al
     The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. GHOUL A , Serova M, Astorgues-Xerri L, Bieche I, et al
     Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. MANNEFELD M , Klassen E, Gaubatz S
     B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
     Cancer Res. 2009;69:4073-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. KIM KY , Baek A, Hwang JE, Choi YA, et al
     Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.
     Cancer Res. 2009;69:4018-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. VON MALTZAHN G , Park JH, Agrawal A, Bandaru NK, et al
     Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas.
     Cancer Res. 2009;69:3892-900.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
111. PAMPALAKIS G , Prosnikli E, Agalioti T, Vlahou A, et al
     A Tumor-Protective Role for Human Kallikrein-Related Peptidase 6 in Breast Cancer Mediated by Inhibition of Epithelial-to-Mesenchymal Transition.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. HU L , Zhu YT, Qi C, Zhu YJ, et al
     Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. QIN L , Liu Z, Chen H, Xu J, et al
     The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. CHENG CJ , Lin YC, Tsai MT, Chen CS, et al
     SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer.
     Cancer Res. 2009;69:3634-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. FRIEBOES HB , Edgerton ME, Fruehauf JP, Rose FR, et al
     Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. ELSHEIKH SE , Green AR, Rakha EA, Powe DG, et al
     Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. CROWDER RJ , Phommaly C, Tao Y, Hoog J, et al
     PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. WANG MY , Chen PS, Prakash E, Hsu HC, et al
     Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. OHASHI E , Kogai T, Kagechika H, Brent GA, et al
     Activation of the PI3 Kinase Pathway By Retinoic Acid Mediates Sodium/Iodide Symporter Induction and Iodide Transport in MCF-7 Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. SHIRLEY SH , Rundhaug JE, Tian J, Cullinan-Ammann N, et al
     Transcriptional Regulation of Estrogen Receptor-{alpha} by p53 in Human Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. ALLI E , Sharma VB, Sunderesakumar P, Ford JM, et al
     Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. ZIPPRICH J , Terry MB, Liao Y, Agrawal M, et al
     Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the new york site of the breast cancer family registry.
     Cancer Res. 2009;69:2966-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. WORKMAN HC , Sweeney C, Carraway KL 3rd
     The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.
     Cancer Res. 2009;69:2845-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. LIZARRAGA F , Poincloux R, Romao M, Montagnac G, et al
     Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
     Cancer Res. 2009;69:2792-800.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. PLOTNIKOV A , Varghese B, Tran TH, Liu C, et al
     Impaired turnover of prolactin receptor contributes to transformation of human breast cells.
     Cancer Res. 2009;69:3165-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
126. HOLSTEGE H , Joosse SA, van Oostrom CT, Nederlof PM, et al
     High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. KRISHNAMACHARY B , Glunde K, Wildes F, Mori N, et al
     Noninvasive Detection of Lentiviral-Mediated Choline Kinase Targeting in a Human Breast Cancer Xenograft.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. ZHANG Y , Martens JW, Yu JX, Jiang J, et al
     Copy Number Alterations that Predict Metastatic Capability of Human Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. NEAL CL , Yao J, Yang W, Zhou X, et al
     14-3-3{zeta} Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. AZUMA K , Urano T, Horie-Inoue K, Hayashi SI, et al
     Association of Estrogen Receptor {alpha} and Histone Deacetylase 6 Causes Rapid Deacetylation of Tubulin in Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. SCHMIDT M , Hengstler JG, von Torne C, Koelbl H, et al
     Coordinates in the Universe of Node-Negative Breast Cancer Revisited.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. SHEPHARD ND , Abo R, Rigas SH, Frank B, et al
     A Breast Cancer Risk Haplotype in the Caspase-8 Gene.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. KHODAREV NN , Pitroda SP, Beckett MA, Macdermed DM, et al
     MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. HOFFMAN AE , Zheng T, Stevens RG, Ba Y, et al
     Clock-Cancer Connection in Non-Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. BROWN JQ , Wilke LG, Geradts J, Kennedy SA, et al
     Quantitative Optical Spectroscopy: A Robust Tool for Direct Measurement of Breast Cancer Vascular Oxygenation and Total Hemoglobin Content In vivo.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. ROBEY IF , Baggett BK, Kirkpatrick ND, Roe DJ, et al
     Bicarbonate increases tumor pH and inhibits spontaneous metastases.
     Cancer Res. 2009;69:2260-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. NARAYAN M , Wilken JA, Harris LN, Baron AT, et al
     Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells.
     Cancer Res. 2009;69:2191-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. PARK SA , Na HK, Kim EH, Cha YN, et al
     4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species.
     Cancer Res. 2009;69:2416-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. CHEN RQ , Yang QK, Lu BW, Yi W, et al
     CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.
     Cancer Res. 2009;69:2663-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. LIU R , Wang L, Chen G, Katoh H, et al
     FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.
     Cancer Res. 2009;69:2252-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. XIAN W , Pappas L, Pandya D, Selfors LM, et al
     Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival.
     Cancer Res. 2009;69:2244-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. IORIO MV , Casalini P, Piovan C, Di Leva G, et al
     microRNA-205 Regulates HER3 in Human Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. SANTISTEBAN M , Reiman JM, Asiedu MK, Behrens MD, et al
     Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. PELICANO H , Lu W, Zhou Y, Zhang W, et al
     Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. GOBERT M , Treilleux I, Bendriss-Vermare N, Bachelot T, et al
     Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
     Cancer Res. 2009;69:2000-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. PARSONS MJ , Patel P, Brat DJ, Colbert L, et al
     Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells.
     Cancer Res. 2009;69:1706-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
147. HIRSCHFELD M , Zur Hausen A, Bettendorf H, Jager M, et al
     Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. WU X , Hawse JR, Subramaniam M, Goetz MP, et al
     The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor {alpha} for Degradation in Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. EUBANK TD , Roberts RD, Khan M, Curry JM, et al
     Granulocyte Macrophage Colony-Stimulating Factor Inhibits Breast Cancer Growth and Metastasis by Invoking an Anti-Angiogenic Program in Tumor-Educated Macrophages.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. DEVY L , Huang L, Naa L, Yanamandra N, et al
     Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.
     Cancer Res. 2009;69:1517-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. NAGASAKI S , Suzuki T, Miki Y, Akahira J, et al
     17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.
     Cancer Res. 2009;69:1392-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. BURGA LN , Tung NM, Troyan SL, Bostina M, et al
     Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.
     Cancer Res. 2009;69:1273-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. SLOMIANY MG , Grass GD, Robertson AD, Yang XY, et al
     Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.
     Cancer Res. 2009;69:1293-301.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. JORDAN VC
     A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. SABNIS G , Schayowitz A, Goloubeva O, Macedo L, et al
     Trastuzumab Reverses Letrozole Resistance and Amplifies the Sensitivity of Breast Cancer Cells to Estrogen.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. CHARAFE-JAUFFRET E , Ginestier C, Iovino F, Wicinski J, et al
     Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. TINNIKOV AA , Yeung KT, Das S, Samuels HH, et al
     Identification of a Novel Pathway That Selectively Modulates Apoptosis of Breast Cancer Cells.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. SUNG B , Murakami A, Oyajobi BO, Aggarwal BB, et al
     Zerumbone Abolishes RANKL-Induced NF-{kappa}B Activation, Inhibits Osteoclastogenesis, and Suppresses Human Breast Cancer-Induced Bone Loss in Athymic Nude Mice.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. HURST DR , Edmonds MD, Scott GK, Benz CC, et al
     Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. HONG SW , Kim CJ, Park WS, Shin JS, et al
     p34SEI-1 Inhibits Apoptosis through the Stabilization of the X-Linked Inhibitor of Apoptosis Protein: p34SEI-1 as a Novel Target for Anti-Breast Cancer Strategies.
     Cancer Res. 2009;69:741-746.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. RAO VA , Klein SR, Agama KK, Toyoda E, et al
     The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase II{alpha} in Breast Cancer Cells.
     Cancer Res. 2009;69:948-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. MEDAROVA Z , Rashkovetsky L, Pantazopoulos P, Moore A, et al
     Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.
     Cancer Res. 2009;69:1182-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. CROSBY ME , Kulshreshtha R, Ivan M, Glazer PM, et al
     MicroRNA regulation of DNA repair gene expression in hypoxic stress.
     Cancer Res. 2009;69:1221-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. CHALUT KJ , Ostrander JH, Giacomelli MG, Wax A, et al
     Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis.
     Cancer Res. 2009;69:1199-204.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
165. JIN C , Yang YA, Anver MR, Morris N, et al
     Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. MIRZOEVA OK , Das D, Heiser LM, Bhattacharya S, et al
     Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition.
     Cancer Res. 2009;69:565-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. WEITZBERG E , Larsen F, Lundberg JO
     Comment re: Nitrite activates estrogen receptor-alpha.
     Cancer Res. 2009;69:718.
     PubMed     Text format     Related articles   
     
     
     
168. MANIE E , Vincent-Salomon A, Lehmann-Che J, Pierron G, et al
     High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors.
     Cancer Res. 2009;69:663-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. MARTINEZ-IGLESIAS O , Garcia-Silva S, Tenbaum SP, Regadera J, et al
     Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
     Cancer Res. 2009;69:501-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. ZHAO X , Lu L, Pokhriyal N, Ma H, et al
     Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells.
     Cancer Res. 2009;69:483-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. WANG SE , Xiang B, Zent R, Quaranta V, et al
     Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton.
     Cancer Res. 2009;69:475-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. AYALA I , Giacchetti G, Caldieri G, Attanasio F, et al
     Faciogenital Dysplasia Protein Fgd1 Regulates Invadopodia Biogenesis and Extracellular Matrix Degradation and Is Up-regulated in Prostate and Breast Cancer.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. SANKPAL NV , Willman MW, Fleming TP, Mayfield JD, et al
     Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion.
     Cancer Res. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. ISSA A , Le TX, Shoushtari AN, Shields JD, et al
     Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
     Cancer Res. 2009;69:349-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. MCCABE MT , Lee EK, Vertino PM
     A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
     Cancer Res. 2009;69:282-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. SHIN DS , Kim HN, Shin KD, Yoon YJ, et al
     Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
     Cancer Res. 2009;69:193-202.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. OCHSNER SA , Steffen DL, Hilsenbeck SG, Chen ES, et al
     GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells.
     Cancer Res. 2009;69:23-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
178. SALA G , Dituri F, Raimondi C, Previdi S, et al
     Phospholipase Cgamma1 is required for metastasis development and progression.
     Cancer Res. 2008;68:10187-96.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. XIANG T , Ohashi A, Huang Y, Pandita TK, et al
     Negative Regulation of AKT Activation by BRCA1.
     Cancer Res. 2008;68:10040-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. HOLLAND D , Hoppe-Seyler K, Schuller B, Lohrey C, et al
     Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
     Cancer Res. 2008;68:9964-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. BARRET JM , Kruczynski A, Vispe S, Annereau JP, et al
     F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
     Cancer Res. 2008;68:9845-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. SAWICKI JA
     Fetal microchimerism and cancer.
     Cancer Res. 2008;68:9567-9.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: